Neurohumoral control mechanisms in congestive heart failure

https://doi.org/10.1016/0002-8703(81)90739-0Get rights and content

Abstract

Neurohumoral vasoconstrictor systems may play an important role in the hemodynamic derangement and natural history of congestive heart failure (CHF) by raising impedance to left ventricular ejection and shifting blood centrally to augment cardiac filling. Activation of the sympathetic nervous system, the renin-angiotensin system, and the antidiuretic hormone-vasopressin system can be demonstrated in clinical CHF by increased plasma levels of norepinephrine, renin activity, and arginine vasopressin. Because the magnitude of increase in each of these hormones varies widely from patient to patient, profiling of the neurohumoral response might provide new insight into the mechanisms of regulation of the circulation in CHF and into specific management with drugs to inhibit or reverse the vasoconstrictor process. Preliminary encouraging experience with converting-enzyme inhibitors to block formation of angiotensin II and alpha-receptor blockers to inhibit norepinephrine-induced vasoconstriction raise the possibility that selective therapy may eventually have a place in long-term management of CHF. Controlled trials in a larger patient population are now required.

References (42)

  • DEL Wilckin et al.

    Effect of alterations in aortic impedance on the performance of the ventricles

    Circ Res

    (1964)
  • JN Cohn

    Vasodilator therapy for heart failure: The influence of impedance on left ventricular performance

    Circulation

    (1973)
  • PA Majid et al.

    Phentolamine for vasodilator treatment of severe heart failure

    Lancet

    (1971)
  • NH Guiha et al.

    Treatment of refractory heart failure with infusion of nitroprusside

    N Engl J Med

    (1974)
  • JA Franciosa et al.

    Hemodynamic improvement after oral hydralazine in left ventricular failure: A comparison with nitroprusside infusion in 16 patients

    Ann Intern Med

    (1977)
  • JE Wood et al.

    Peripheral venoconstriction in human congestive heart failure

    Circulation

    (1956)
  • R Zelis

    The contribution of local factors to the elevated venous tone of congestive heart failure

    J Clin Invest

    (1974)
  • J Gero et al.

    The role of parameters of pulsating pressure in the stimulation of intracarotid receptors

    Arch Int Pharmacodyn Ther

    (1962)
  • IJ Kopin

    Plasma levels of norepinephrine

    Ann Intern Med

    (1978)
  • H Brunner

    Modulation of sympathetic tone at the neuroeffector level

  • A Vendsalu

    Studies on adrenaline and noradrenaline in human plasma

    Acta Physiol Scand

    (1960)
  • Cited by (134)

    • Advanced (stage D) heart failure: A statement from the heart failure society of america guidelines committee

      2015, Journal of Cardiac Failure
      Citation Excerpt :

      The Enhanced Feedback for Effective Care (EFFECT) study derived a multivariable risk model using vital signs, routine laboratories, and comorbidities at the time of admission to predict 30-day and 1-year mortality.36 The interplay of neurohormonal activation, inflammation, and myocardial remodeling in the pathophysiology of heart failure has been well described.37–40 In HFrEF, this insidious, variable, and persistent process ultimately overwhelms the benefits of conventional heart failure therapy and the disease progresses to an advanced stage.

    • Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges

      2013, International Journal of Cardiology
      Citation Excerpt :

      The understanding of heart failure pathophysiology has evolved considerably from an initial primary focus on low cardiac output and abnormal hemodynamics to the recognition that activated neurohormones promote cardiac remodeling and heart failure progression (both systolic and diastolic) and are associated with worse outcomes [1–5].

    • Bidirectional neuro-glial signaling modalities in the hypothalamus: Role in neurohumoral regulation

      2013, Autonomic Neuroscience: Basic and Clinical
      Citation Excerpt :

      By controlling these two major information processing systems, specific neuronal networks within the central nervous system (CNS) generate adaptive neurohumoral responses, which are necessary for proper cardiovascular, fluid and energy balance system regulation. Neurohumoral activation is not only important within the context of adaptive physiological responses, but it is now also recognized to be a critical pathophysiological component in numerous disease conditions, including hypertension, heart failure, stress, and the metabolic syndrome (Cohn et al., 1981; Haywood et al., 1985; Middlekauff and Mark, 1998; Brook and Julius, 2000; Felder et al., 2001; Perez-Tilve et al., 2006). In the case of heart failure, for example, a compelling correlation between neurohumoral activation, morbidity and mortality in heart failure patients has been established (Cohn et al., 1984).

    • The Pathophysiology of Heart Failure

      2012, Muscle: Fundamental Biology and Mechanisms of Disease
    • Natural History of End-stage LV Dysfunction: Has It Improved from the Classic Franciosa and Cohn Graph?

      2011, Cardiology Clinics
      Citation Excerpt :

      In the early 1970s, Drs Franciosa and Cohn showed acute improvement in hemodynamics, exercise capacity, and metabolic effects with vasodilation using nitroprusside, hydralazine, and isosorbide dinitrate in patients with advanced left ventricular (LV) systolic failure.30–32 The importance of neurohumoral regulation was further elucidated in the late 1970s with description of the role of sympathetic nervous system, renin-angiotensin system, and antidiuretic hormone, resulting in increased norepinephrine levels and hyponatremia.33 Several clinical trials followed, testing inhibition using angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), aldosterone receptor antagonists and β-blockers to sequentially counter neurohumoral activation, resulting in significant improvements in morbidity and mortality.

    View all citing articles on Scopus

    Supported in part by grants from the National Heart, Lung and Blood Institute (HL22977) and from the Veterans Administration Research Service.

    View full text